LIFECARE ASA (LIFE.OL) Stock Fundamental Analysis

OSL:LIFE • NO0013355859

0.424 NOK
+0 (+0.95%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LIFE. LIFE was compared to 63 industry peers in the Health Care Equipment & Supplies industry. LIFE has a bad profitability rating. Also its financial health evaluation is rather negative. LIFE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • LIFE had negative earnings in the past year.
  • In the past year LIFE has reported a negative cash flow from operations.
  • LIFE had negative earnings in each of the past 5 years.
  • In the past 5 years LIFE always reported negative operating cash flow.
LIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFLIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -144.73%, LIFE is not doing good in the industry: 93.65% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -144.73%
ROE N/A
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
LIFE.OL Yearly ROA, ROE, ROICLIFE.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

  • LIFE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIFE.OL Yearly Profit, Operating, Gross MarginsLIFE.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • LIFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LIFE has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for LIFE has been reduced compared to 5 years ago.
  • LIFE has a better debt/assets ratio than last year.
LIFE.OL Yearly Shares OutstandingLIFE.OL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LIFE.OL Yearly Total Debt VS Total AssetsLIFE.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -7.83, we must say that LIFE is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -7.83, LIFE is not doing good in the industry: 87.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.83
ROIC/WACCN/A
WACC6.7%
LIFE.OL Yearly LT Debt VS Equity VS FCFLIFE.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 0.22 indicates that LIFE may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.22, LIFE is doing worse than 93.65% of the companies in the same industry.
  • LIFE has a Quick Ratio of 0.22. This is a bad value and indicates that LIFE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of LIFE (0.22) is worse than 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
LIFE.OL Yearly Current Assets VS Current LiabilitesLIFE.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • LIFE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.54%.
  • The Revenue for LIFE has decreased by -26.10% in the past year. This is quite bad
  • LIFE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.13% yearly.
EPS 1Y (TTM)-40.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.83%
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-65.22%

3.2 Future

  • Based on estimates for the next years, LIFE will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.88% on average per year.
  • The Revenue is expected to grow by 53.02% on average over the next years. This is a very strong growth
EPS Next Y8.12%
EPS Next 2Y10.07%
EPS Next 3Y8.88%
EPS Next 5YN/A
Revenue Next Year-75%
Revenue Next 2Y15.47%
Revenue Next 3Y53.03%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIFE.OL Yearly Revenue VS EstimatesLIFE.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
LIFE.OL Yearly EPS VS EstimatesLIFE.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LIFE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LIFE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LIFE.OL Price Earnings VS Forward Price EarningsLIFE.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIFE.OL Per share dataLIFE.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.07%
EPS Next 3Y8.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LIFE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIFECARE ASA

OSL:LIFE (2/12/2026, 7:00:00 PM)

0.424

+0 (+0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-27
Earnings (Next)N/A
Inst Owners7.56%
Inst Owner ChangeN/A
Ins Owners7.41%
Ins Owner ChangeN/A
Market Cap8.08M
Revenue(TTM)1.82M
Net Income(TTM)-123.69M
AnalystsN/A
Price Target36.72 (8560.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)65.14%
EPS NY rev (3m)66.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-50%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.43
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.52
EYN/A
EPS(NY)-1.31
Fwd EYN/A
FCF(TTM)-4.93
FCFYN/A
OCF(TTM)-4.62
OCFYN/A
SpS0.1
BVpS-0.32
TBVpS-0.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -144.73%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.13%
Cap/Sales 326.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -7.83
F-Score1
WACC6.7%
ROIC/WACCN/A
Cap/Depr(3y)168.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)55.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.83%
EPS Next Y8.12%
EPS Next 2Y10.07%
EPS Next 3Y8.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-65.22%
Revenue Next Year-75%
Revenue Next 2Y15.47%
Revenue Next 3Y53.03%
Revenue Next 5YN/A
EBIT growth 1Y-139.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.41%
EBIT Next 3Y6.74%
EBIT Next 5YN/A
FCF growth 1Y-103.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-75.56%
OCF growth 3YN/A
OCF growth 5YN/A

LIFECARE ASA / LIFE.OL FAQ

What is the ChartMill fundamental rating of LIFECARE ASA (LIFE.OL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LIFE.OL.


Can you provide the valuation status for LIFECARE ASA?

ChartMill assigns a valuation rating of 0 / 10 to LIFECARE ASA (LIFE.OL). This can be considered as Overvalued.


What is the profitability of LIFE stock?

LIFECARE ASA (LIFE.OL) has a profitability rating of 0 / 10.


What is the earnings growth outlook for LIFECARE ASA?

The Earnings per Share (EPS) of LIFECARE ASA (LIFE.OL) is expected to grow by 8.12% in the next year.


Is the dividend of LIFECARE ASA sustainable?

The dividend rating of LIFECARE ASA (LIFE.OL) is 0 / 10 and the dividend payout ratio is 0%.